These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31611199)

  • 1. Poly (ADP-ribose) polymerase-1 Binding Protein Facilitates Lung Adenocarcinoma Cell Proliferation and Correlates with Poor Prognosis.
    Xu D; Tao Z; Tang X; He JK
    Ann Clin Lab Sci; 2019 Sep; 49(5):574-580. PubMed ID: 31611199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of C5orf34 promotes lung adenocarcinoma migration and is correlated with worse prognosis.
    He D; Wu Z; He J; Wang Y; Li Z; Gao S
    Gene; 2019 May; 696():47-53. PubMed ID: 30771479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients.
    Han M; Wang B; Zhu M; Zhang Y
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):614-621. PubMed ID: 31292940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
    Ji Z; Pan X; Shang Y; Ni DT; Wu FL
    Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBX2, as a tumor promoter in lung adenocarcinoma, enhances cells viability, invasion and migration by regulating the AKT/ERK signaling pathway.
    Wang Y; Hui J; Li R; Fu Q; Yang P; Xiao Y; Hui J
    J Gene Med; 2020 Feb; 22(2):e3147. PubMed ID: 31758726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Dig Dis Sci; 2019 Oct; 64(10):2878-2892. PubMed ID: 30949905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
    Li J; Zhang W; Xia H; Liu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma.
    Wang DW; Zheng HZ; Cha N; Zhang XJ; Zheng M; Chen MM; Tian LX
    Technol Cancer Res Treat; 2020; 19():1533033820957006. PubMed ID: 33000678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
    Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.
    Wang X; Xu W; Zhan P; Xu T; Jin J; Miu Y; Zhou Z; Zhu Q; Wan B; Xi G; Ye L; Liu Y; Gao J; Li H; Lv T; Song Y
    J Cell Mol Med; 2018 Apr; 22(4):2177-2189. PubMed ID: 29377583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SKA3 Up-regulation Promotes Lung Adenocarcinoma Growth and is a Predictor of Poor Prognosis.
    Sun RL; Liu FJ; Wu X; Wang LS; Wang PF; Zhang CL
    Open Life Sci; 2019 Jan; 14():392-399. PubMed ID: 33817174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEAD4 promotes tumor development in patients with lung adenocarcinoma via ERK signaling pathway.
    Gu C; Huang Z; Chen X; Liu C; Rocco G; Zhao S; Xie H; Chen J; Dai C; Chen C
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165921. PubMed ID: 32800942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
    Zhao CC; Chen J; Niu RF; Liu Y; Zhang CG
    Oncol Rep; 2018 Dec; 40(6):3392-3404. PubMed ID: 30272365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated integrin α6 expression is involved in the occurrence and development of lung adenocarcinoma, and predicts a poor prognosis: a study based on immunohistochemical analysis and bioinformatics.
    Shen J; Xu J; Chen B; Ma D; Chen Z; Li JC; Zhu C
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1681-1693. PubMed ID: 31175464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and functions of Ehm2 transcript variants in lung adenocarcinoma.
    Li S; Ma J; Si Y; Cheng S; Hu M; Zhi X; Li B; Yu H; Jiang WG
    Int J Oncol; 2019 May; 54(5):1747-1758. PubMed ID: 30816447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
    Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
    Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.